Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Double homeobox 4 like 35 (DUX4L35) is annotated in genomic databases as a pseudogene and is named for its similarity to the DUX4 gene family. DUX4L35 has no described protein product, molecular function, or role in disease. It is not considered a therapeutic target, and no biological, disease-associated, or pharmacological information is attributed to this pseudogene in current research or curation[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double homeobox 4 like 35 (DUX4L35).